Russian COVID-19 vaccine approval imminent, source says

07/31/2020 03:00 | NaN

Russian COVID-19 vaccine approval imminent, source says

"This study shows that even just a single immunization with the Ad26 vaccine leads to neutralizing antibody responses and robust protection of monkeys against COVID-19", said Dr. Dan Barouch, a vaccine researcher at Beth Israel Deaconness who led the research in collaboration with J&J.

Moderna announced Monday that its COVID-19 vaccine candidate, identified as mRNA-1273, is moving forward to the final phase of testing. "Russian Federation will have got there first", said Kirill Dmitriev, the head of RDIF, in an interview with CNN.

"We haven't seen any sign that we have been hacked in the context of this vaccine", Soriot said. The Subject Expert Committee (SEC) on COVID-19 which held its meeting on Tuesday deliberated on the application by SII and asked the Pune-based firm to revise its protocol for the phase 2 and 3 clinical trials, besides seeking some additional information.

"Rochester has a long history of national leadership in vaccine development, the study of emerging infectious diseases, and understanding how the human immune system reacts to infection", Falsey says. "Second, individual countries can negotiate to those people whose vaccine gets successful", he said.

This is the first time an experimental Covid-19 vaccine tested in nonhuman primates has been shown to produce such rapid viral control in the upper airway, the investigators noted.

Moncef Slaoui, chief adviser to the U.S. government's Covid-19 vaccine effort, Operation Warp Speed, said building on earlier, tested vaccine platforms allows speedier development of vaccines while still being safe.

While some global vaccines have entered the third phase of trials, the Russian vaccine is yet to complete its second phase, which the developers plan to complete by August 3.

Kirill Dmitriev, the head of Russia's sovereign wealth fund, which is financing the Gamaleya trials, said the country hoped to be the first to approve a vaccine.

"This means that there are 24 vaccine candidates in the clinical trial stage are in phase I, II or III done on human volunteers at multi-centric sites".

The conference also saw speakers from several leading research institutions in Europe as well representatives from collectives such as the Coalition for Epidemic Preparedness that are involved in myriad vaccine development projects.

"These are Phase 1 studies".

The testing procedure will follow guidelines for clinical trials of vaccines set by the U.S. Food and Drugs Administration and will be conducted in "nearly 100" research locations in the country, according to Moderna. The allegations have been denied by Moscow.

Add comment